BeStock  
Stocks › Biotechnology › ARQT

Arcutis Biotherapeutics ARQT

US equityMarket cap rank #2353Biotechnology
$26.36 −$0.81 (-2.98%)
Market closed · Nov 22, 5:10 am ET · Last extended-hours $26.40 +0.15%
Open$26.91
Prev close$27.17
Day range$26.29 – $27.47
Volume1.29M
Market cap$3.33B
P/E (TTM)119.8
Dividend yield–

Analyst view

ConsensusBuy
Analysts5
Average target$42.00+59.3% vs. price
  • Buy 100%
Low $38.00Now $26.36Avg $42.00High $48.00

Recent rating changes

The last 20 actions on file set price targets from $34.00 to $48.00, averaging $37.15.

DateFirmRatingTarget
5 Nov 2026 Morgan Stanley BUY $38.00
5 Nov 2026 H.C. Wainwright BUY $40.00
4 Nov 2026 TD Cowen BUY $40.00
19 Oct 2026 Guggenheim BUY $44.00
15 Oct 2026 Cantor Fitzgerald BUY $48.00
10 Aug 2026 H.C. Wainwright BUY $34.00
6 Aug 2026 Morgan Stanley BUY $38.00
6 Aug 2026 Needham BUY $40.00
6 Aug 2026 H.C. Wainwright BUY $34.00
5 Aug 2026 TD Cowen BUY $35.00
5 Aug 2026 Guggenheim BUY $38.00
16 Jul 2026 Guggenheim BUY $35.00
30 Jun 2026 Needham BUY $36.00
11 May 2026 H.C. Wainwright BUY $34.00
7 May 2026 TD Cowen BUY $35.00
7 May 2026 Morgan Stanley BUY $34.00
7 May 2026 Needham BUY $36.00
7 May 2026 H.C. Wainwright BUY $34.00
23 Apr 2026 TD Cowen BUY $35.00
22 Apr 2026 Morgan Stanley BUY $35.00

Discussion

No comments yet — be the first to weigh in on ARQT.

Sign in to join the discussion.

Scroll to Top